相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p53, cancer and the immune response
Julianne Blagih et al.
JOURNAL OF CELL SCIENCE (2020)
Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer
Sohyun Hwang et al.
SCIENTIFIC REPORTS (2020)
Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
Rachael M. Zemek et al.
FRONTIERS IN IMMUNOLOGY (2020)
The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types
Sungjae Kim et al.
SCIENTIFIC REPORTS (2020)
Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Sun Min Lim et al.
IMMUNE NETWORK (2020)
Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma
Hui Yu et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis
Melinda S. Schuurman et al.
ACTA ONCOLOGICA (2019)
Molecular and Morphological Profiling of Lung Cancer: A Foundation for Next-Generation Pathologists and Oncologists
Jumpei Kashima et al.
CANCERS (2019)
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma
Tao Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Tumor-associated macrophages affect the biological behavior of lung adenocarcinoma A549 cells through the PI3K/AKT signaling pathway
Shiyang Yuan et al.
ONCOLOGY LETTERS (2019)
Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer
Donghai Xiong et al.
SCIENTIFIC REPORTS (2019)
Distinct signatures of lung cancer types: aberrant mucin O-glycosylation and compromised immune response
Marta Lucchetta et al.
BMC CANCER (2019)
Tumor mutation burden: from comprehensive mutational screening to the clinic
Francesca Galuppini et al.
CANCER CELL INTERNATIONAL (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
Meichen Yin et al.
ONCOTARGETS AND THERAPY (2019)
Increased regulatory B cells are involved in immune evasion in patients with gastric cancer
Yuki Murakami et al.
SCIENTIFIC REPORTS (2019)
Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
Jong Yeob Kim et al.
CANCERS (2019)
Characterization of Tumor-Suppressor Gene Inactivation Events in 33 Cancer Types
Peilin Jia et al.
CELL REPORTS (2019)
Mutations in DNA repair genes are associated with increased neoantigen burden and a distinct immunophenotype in lung squamous cell carcinoma
Young Kwang Chae et al.
SCIENTIFIC REPORTS (2019)
Global Epidemiology of Lung Cancer
Julie A. Barta et al.
ANNALS OF GLOBAL HEALTH (2019)
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein et al.
IMMUNITY (2018)
Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma
Jeong-Sun Seo et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Diverse Functions of Macrophages in Different Tumor Microenvironments
Ming Yang et al.
CANCER RESEARCH (2018)
Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor
Jeong-Sun Seo et al.
SCIENTIFIC REPORTS (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies (vol 33, pg 581, 2018)
Roberta Zappasodi et al.
CANCER CELL (2018)
Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer
David Balli et al.
CLINICAL CANCER RESEARCH (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Characterization of children with recurrent eczema herpeticum and response to treatment with interferon-gamma
Kavita Darji et al.
PEDIATRIC DERMATOLOGY (2017)
Identification of a RNA-Seq based prognostic signature with five lncRNAs for lung squamous cell carcinoma
Rui-xue Tang et al.
ONCOTARGET (2017)
Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer
Yuan-Xiang Shi et al.
BMC GENOMICS (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Putting p53 in Context
Edward R. Kastenhuber et al.
CELL (2017)
Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment
Yan Cui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim et al.
MEDIATORS OF INFLAMMATION (2016)
Emerging roles of p53 and other tumour-suppressor genes in immune regulation
Cesar Munoz-Fontela et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Lung cancer staging: a true story
Klaus F. Rabe
LANCET RESPIRATORY MEDICINE (2015)
New insights into IL-12-mediated tumor suppression
S. Tugues et al.
CELL DEATH AND DIFFERENTIATION (2015)
VISTA Is an Immune Checkpoint Molecule for Human T Cells
J. Louise Lines et al.
CANCER RESEARCH (2014)
Roles of tumor suppressors in regulating tumor-associated inflammation
L. Yang et al.
CELL DEATH AND DIFFERENTIATION (2014)
Tumor suppressor mechanisms in immune aging
Yan Liu et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
分享论文
